Brief: G2s2 Capital Says Co's Unit Has Increased Its Ownership Of Knight Therapeutics
June 14 (Reuters) - G2S2 Capital:
* G2S2 CAPITAL INC - CO'S UNIT HAS INCREASED ITS OWNERSHIP
OF
KNIGHT THERAPEUTICS TO OVER 10% OF KNIGHT'S OUTSTANDING COMMON
SHARES
Source text for Eikon: ID:nCNWGMgvHa
Further company coverage: GUD.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil